Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

JNJ 101.15 +0.02 (0.02%)
price chart
FBI investigating Johnson & Johnson over hysterectomy device pulled from ...
The FBI is questioning makers of a surgical device that can spread cancer cells in female patients, asking Johnson & Johnson officials what the manufacturing giant knew about the tool before yanking it out of service in 2014, according to a new report.
Johnson & Johnson Laparoscopic Power Morcellator Lawsuits Filed Over ...  The Inquisitr
Johnson & Johnson Probed Over Laparoscopic Power Morcellator  Newsmax
Johnson & Johnson accepts offer from Cardinal Health for Cordis unit
Johnson & Johnson said it made the decision to sell in consultation with works councils and labor unions. Cardinal Health had previously said that it expects the deal to add more than 20 cents per share to its fiscal 2017 adjusted earnings.
Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal ...  PR Newswire (press release)
Johnson & Johnson accepts $1.94 billion offer from Cardinal Health for ...  Vancouver Sun
Johnson & Johnson's 3 Most Important Numbers
There aren't many companies investors can buy that offer a true "set it and forget it" feel, but healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is one of them. Shares of the healthcare giant have risen a split-adjusted 6,650% over the trailing ...
How to Use Options to Profit From Johnson & Johnson's Success
NEW YORK (TheStreet) -- Johnson & Johnson (JNJ - Get Report) has been on my watch list for several months now because I have liked the trading action of the stock relative to the overall stock market averages.
Johnson & Johnson (JNJ) - Investment Analysts' Recent Ratings Changes  Mideast Time
4 Notable Runners: Johnson & Johnson (JNJ), Hitachi (HTHIY), Synergy ...  Techsonian (press release)
Johnson & Johnson Expects Lucrative Return on Drug Pipeline
Johnson & Johnson is predicting big returns from its prescription drug business, both financially and medically, as it develops treatments and strategies to intervene earlier and prevent or reduce the damage from several conditions, including Alzheimer ...
Johnson & Johnson Pegs Its Long-Term Growth Potential On Prevention  Forbes
Women are suing Johnson & Johnson over talcum powder
Johnson & Johnson's Shower to Shower is marketed as, "Just a sprinkle a day helps keep odor away." Yet now many women have filed lawsuits against Johnson & Johnson, arguing that talc in this and other products led to their ovarian cancers and that the ...
Women File Lawsuit Against Johnson & Johnson Over Talcum Powder  The Inquisitr
Johnson & Johnson's Piping-Hot Pipeline
We believe that Johnson & Johnson is positioned for solid growth, driven by strength of its pharmaceuticals business, recovery in the consumer segment and market stabilization coupled with share gain in medical devices and diagnostics.
Johnson & Johnson reviews global media
A spokeswoman from Johnson & Johnson said: "Our goal is to ensure we have the best media capability in strategy, planning and buying against evolved business strategies and marketing frameworks for Johnson & Johnson's business sectors and brands ...
Johnson & Johnson Now Offering Employees Up To 17 Weeks Of Parental Leave
This week, Johnson & Johnson made an exciting announcement that will hopefully set a precedent for other major companies in the U.S.
Johnson & Johnson To Give 8 Weeks Paid Leave For New Moms And Dads  RTT News
Johnson & Johnson's Schizophrenia Drug Wins FDA Approval
Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, developed the atypical antipsychotic Invega Trinza, which was granted priority review in January.
Johnson & Johnson''s Schizophrenia Drug Gains FDA''s ...  Nasdaq
Johnson & Johnson (JNJ) Announces FDA Approval of Invega Trinza as ...  StreetInsider.com